GelStat Corp. (OTCMKTS:GSAC) Sees Large Growth in Short Interest

GelStat Corp. (OTCMKTS:GSAC – Get Free Report) was the target of a large growth in short interest in the month of May. As of May 29th, there was short interest totaling 100,000 shares, a growth of ∞ from the May 14th total of 0 shares. Approximately 0.0% of the shares of the stock are short sold. Based on an average daily trading volume, of 7,458,359 shares, the days-to-cover ratio is currently 0.0 days.

GelStat Price Performance

Shares of GelStat stock remained flat at $0.00 during midday trading on Tuesday. The company had a trading volume of 3,749 shares, compared to its average volume of 1,679,876. GelStat has a 1-year low of $0.00 and a 1-year high of $0.00.

Get GelStat alerts:

GelStat Company Profile

(Get Free Report)

GelStat Corporation, a consumer health care company, engages in the research, development, and marketing of over-the-counter and other non-prescription consumer health care products. Its products include GelStat Migraine, a patented solution used for pain relief from migraine headaches; Chews 2 Lose, an appetite suppressant gum for diet aide; All Natural Speed, an energy supplement product; and GelStat Sleep, a product for relief from sleep disorders and its associated symptoms. The company sells its products to retailers, wholesalers, specialty distributors, and catalog merchandisers both directly and through external sales brokers.

Featured Articles

• Five stocks we like better than GelStat
• AST SpaceMobile Announces Launch Date for Its Next 3 BlueBird Satellites
• Is Lennar Finally Turning the Corner After Its Housing Slump?
• AI Memory Demand Has Turned These 5 S&P 500 Stocks Into Market Leaders
• 3 Dividend Kings With Income, Stability, and a Possible Catalyst

Receive News & Ratings for GelStat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GelStat and related companies with MarketBeat.com's FREE daily email newsletter.